Dirty air may trigger painful rheumatoid arthritis flares

A recent study indicates that air pollution could potentially exacerbate rheumatoid arthritis symptoms and increase the frequency of painful flare-ups, according to findings published in the Annals of the Rheumatic Diseases. The research, conducted by South Korean scientists, suggests that fine particulate matter (PM2.5) found in dust, soot, and smoke may be the primary contributor to this link between air quality and rheumatoid arthritis.

Published in the EULAR Journal, the study provides important insights for both healthcare professionals treating RA and policymakers working to protect public health. Rheumatoid arthritis is a chronic autoimmune condition affecting an estimated 0.5% to 1% of adults worldwide, characterized by inflammation and damage to joints and broader systemic symptoms.

While genetics, immune function changes, and environmental exposures contribute to its development, several environmental factors may influence both the onset and progression of the disease. Smoking, for instance, is already recognized as a significant risk factor. Previous research has also examined temperature, humidity, silica, and other pollutants.

This latest South Korean study aimed to determine whether air pollution could also impact the activity and flare-ups of RA in patients who already have the condition, as well as explore the underlying biological mechanisms behind this potential connection. The prospective cohort study followed 1,070 individuals with RA at a major medical center in South Korea for four years, from 2021 to 2024.

Researchers collected data from 12,583 outpatient visits conducted under real-world clinical conditions, examining monthly levels of six common air pollutants, including sulfur dioxide, nitrogen dioxide, ozone, carbon monoxide, PM10, and PM2.5. These measurements were then compared with disease activity and flare outcomes recorded during each visit.

After accounting for various factors that could influence the results, such as patient demographics, serologic status, medication use, socioeconomic conditions, and weather-related variables, the researchers found that higher PM2.5 levels were associated with increased disease activity and flare risk, particularly when exposed to elevated PM2.5 for more than two weeks.

Lead investigator Eun Bong Lee explains that PM2.5 particles, which are extremely small and can be inhaled, may stimulate excessive production of reactive oxygen species. These harmful molecules can cause cellular stress, damage DNA, and trigger inflammatory responses in various organs, potentially leading to greater RA activity and more frequent flares.

The study's findings carry significant implications for public health policy. While further research is needed to determine whether improving air quality can directly reduce disease activity in RA patients, the researchers recommend that individuals with RA avoid prolonged exposure to poor air quality, especially high PM2.5 levels.

Dr. Josef Smolen, Editor-in-Chief of the Annals of the Rheumatic Diseases, notes that the study has undergone thorough peer review and highlights the importance and interest of the findings among reviewers. However, he emphasizes the need for additional studies to confirm whether reducing pollution exposure or enhancing air quality can directly lower disease activity in people with RA, acknowledging that the observations apply to the studied Korean population.